The DOI matches its Crossref record; 26 of the 26 references it cites were found in a registry or an index.
Drug-Resistant E. coli Bacteremia Transmitted by Fecal Microbiota Transplant
Open accessAbstract
bacteremia occurred after they had undergone FMT in two independent clinical trials; both cases were linked to the same stool donor by means of genomic sequencing. One of the patients died. Enhanced donor screening to limit the transmission of microorganisms that could lead to adverse infectious events and continued vigilance to define the benefits and risks of FMT across different patient populations are warranted.
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In the citing paper
“FMT may also carry the risk of unintended introduction of pathogens and antibiotic-resistant microbes into the recipients.749,750”
From Microbiota–gut–brain axis and its therapeutic applications in neurodegenerative diseases (2024) · cites this paper as [749]
In the citing paper
“In 2019, it was reported that in two independent clinical trials, two patients developed bacteremia with extended-spectrum β-lactamase (ESBL)-producing Escherichia coli after receiving FMT from the same donor, and one patient died [136].”
From Gut microbiota influence immunotherapy responses: mechanisms and therapeutic strategies (2022) · cites this paper as [136]
In the citing paper
“This issue has become extremely timely after the transmission of an extended-spectrum b -lactamase-producing Escherichia coli strain from a stool donor to two immunocompromised recipients who developed bacteremia, with a fatal outcome in one case. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Indeed, two cases of MDR bacteria transmission with life-threatening complications have been described in patients with cirrhosis and hematological malignancy after repeated FMT. 46”
From Key determinants of success in fecal microbiota transplantation: From microbiome to clinic (2023) · cites this paper as [46]
In the citing paper
“Although FMT is generally recognized as safe, with no or limited side effects,33 unexpected toxicity has been reported, e.g., extended-spectrum beta-lactamase (ESBL)-producing Escherichia coli bacteremia in two patients who received FMT.34”
From Faecalibacterium prausnitzii strain EXL01 boosts efficacy of immune checkpoint inhibitors (2024) · cites this paper as [34]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Duodenal Infusion of Donor Feces for Recurrent Clostridium difficile
van Nood, E., Vrieze, A., Nieuwdorp, M., Fuentes, S., Zoetendal, E. G., de Vos, W. M., Visser, C. E., Kuijper, E. J., Bartelsman, J. F. W. M., Tijssen, J. G. P., et al. (2013) · New England Journal of Medicine · doi:10.1056/nejmoa1205037 · Cited by 3,708
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J. S., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/cix1085 · Cited by 2,690
European consensus conference on faecal microbiota transplantation in clinical practice
Cammarota, G., Ianiro, G., Tilg, H., Rajilić-Stojanović, M., Kump, P., Satokari, R., Sokol, H., Arkkila, P., Pintus, C., Hart, A., et al. (2017) · Gut · doi:10.1136/gutjnl-2016-313017 · Cited by 1,207
McDonald, L. C., Gerding, D. N., Johnson, S., Bakken, J., Carroll, K. C., Coffin, S. E., Dubberke, E. R., Garey, K. W., Gould, C. V., Kelly, C. P., et al. (2018) · Clinical Infectious Diseases · doi:10.1093/cid/ciy149 · Cited by 1,163
Beceiro, A., Tomás, M., & Bou, G. (2013) · Clinical Microbiology Reviews · doi:10.1128/cmr.00059-12 · Cited by 1,118
Kassam, Z., Lee, C. H., Yuan, Y., & Hunt, R. H. (2013) · American Journal of Gastroenterology · doi:10.1038/ajg.2013.59 · Cited by 904
Pathological bacterial translocation in liver cirrhosis
Wiest, R., Lawson, M. A., & Geuking, M. B. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.07.044 · Cited by 826
Youngster, I., Russell, G. H., Pindar, C., Ziv-Baran, T., Sauk, J., & Hohmann, E. L. (2014) · JAMA · doi:10.1001/jama.2014.13875 · Cited by 629
Self-citationSchürch, A. C., Arredondo-Alonso, S., Willems, R. J. L., & Goering, R. V. (2018) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2017.12.016 · Cited by 534
Mullish, B. H., Quraishi, M. N., Segal, J. P., McCune, V. L., Baxter, M., Marsden, G. L., Moore, D., Colville, A., Bhala, N. B., Iqbal, T. H., et al. (2018) · Gut · doi:10.1136/gutjnl-2018-316818 · Cited by 344
Flagged first, then by citations
Research works printed but not linked: 1
- Clinical and Laboratory Standards Institute. Performance standards for antimicrobial susceptibility testing: CLSI supplement M100. 29th ed. Wayne, PA: Clinical and Laboratory Standards Institute, 2019.
Cited by
Sorted by citations
Items 901–1,000 of 1,000
Alexander, J. B., Mullish, B. H., Thomas, L., Weersma, R. K., Sokol, H., Roberts, L. A., Edwards, L. A., Emmanuel, A. V., Gerasimidis, K., Hall, L. J., et al. (2026) · Gut · doi:10.1136/gutjnl-2026-338252 · Cited by 5
The role of the gut microbiome in antibiotic-driven antimicrobial resistance
Joshi, G., Rani, S., Bharti, D., Panda, N., Chavan, P., Mathpal, S., Ramaiah, S., & Anbarasu, A. (2026) · Frontiers in Microbiology · doi:10.3389/fmicb.2026.1856738 · Cited by 3
Narváez, N. S. F., & Jerves, J. A. T. (2023) · Revista Vive · doi:10.33996/revistavive.v6i16.207 · Cited by 3
Swiss expert opinion: current approaches in faecal microbiota transplantation in daily practice
Rossier, L., Matter, C., Burri, E., Galpérine, T., Hruz, P. L., Juillerat, P., Schoepfer, A. M., Vavricka, S. R., Zahnd, N., Décosterd, N., et al. (2023) · Swiss Medical Weekly · doi:10.57187/smw.2023.40100 · Cited by 4
Assuring safety of fecal microbiota transplantation in the COVID ‐19 era: A single‐center experience
Chang, T.-E., Lee, K., Lee, P., Wang, Y., Lin, Y.-T., Huang, H., Luo, J., Ho, H., Huang, Y., Hou, M., et al. (2023) · JGH Open · doi:10.1002/jgh3.12979 · Cited by 3
The Interplay between Mycobacterium tuberculosis and Human Microbiome
Nguyen, M., Ahn, P., Dawi, J., Gargaloyan, A., Kiriaki, A., Shou, T., Wu, K. C. ‐., Yazdan, K., & Venketaraman, V. (2024) · Clinics and Practice · doi:10.3390/clinpract14010017 · Cited by 4
Itoh, K., & Matsueda, S. (2024) · Biomedicines · doi:10.3390/biomedicines12040803 · Cited by 3
Antibiotic subclasses differentially perturb the gut microbiota in kidney transplant recipients
Dong, H., Li, R., Zhao, N., Dadhania, D. M., Suthanthiran, M., Lee, J. R., & Ling, W. (2024) · Frontiers in Transplantation · doi:10.3389/frtra.2024.1400067 · Cited by 3
Shelat, P., & Rawal, R. (2025) · Journal of Microbiology Biotechnology and Food Sciences · doi:10.55251/jmbfs.12612 · Cited by 3
Faecal microbiota transplantation for urinary tract infections
Belvončíková, P., & Gardlík, R. (2025) · Clinical Microbiology and Infection · doi:10.1016/j.cmi.2025.09.018 · Cited by 3
Mons, E., Henderickx, J. G. E., Sanders, I. M. J. G., Rader, A. G., Perkins, C. E., Stel, F. M., van Groesen, E., Smits, W. K., Theriot, C. M., & Martin, N. I. (2025) · Nature Communications · doi:10.1038/s41467-025-64067-w · Cited by 3
Halabi, J. E., Palmer, N., Fox, K. P., Kohane, I. S., & Farhat, M. R. (2021) · Journal of Gastroenterology · doi:10.1007/s00535-021-01822-y · Cited by 3
Russian experience in fecal microbiota transplantation
Vlassov, V. V., & Morozov, V. V. (2023) · Экспериментальная и клиническая гастроэнтерология · doi:10.31146/1682-8658-ecg-212-4-113-120 · Cited by 3
Significant Publications on Infectious Diseases Pharmacotherapy in 2022
Teran, N. S., Buckley, V., Britt, R. S., Ikwuagwu, J. O., Thomas, J. L., Zaki, A., Olson, K., Stramel, S., & on behalf of the Houston Infectious Diseases Network (2023) · Journal of Pharmacy Practice · doi:10.1177/08971900231194200 · Cited by 3
Future Microbiome Therapeutics for Clostridioides difficile Infection
Fischer, M., & Ray, A. (2023) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000002576 · Cited by 3
Dietary Supplements and the Gut–Brain Axis: A Focus on Lemon, Glycerin, and Their Combinations
Guo, T. L., Navarro, J., Luna, M. I., & Xu, H. S. (2024) · Dietetics · doi:10.3390/dietetics3040034 · Cited by 3
Die Rolle des Darmmikrobioms beim idiopathischen Parkinson-Syndrom
Unger, M. M., Becker, A., Keller, A., Schäfer, K., Schwiertz, A., & Oertel, W. H. (2020) · Der Nervenarzt · doi:10.1007/s00115-020-01011-x · Cited by 3
Chauhan, A., Apostolov, R., van Langenberg, D. R., & Garg, M. (2021) · Internal Medicine Journal · doi:10.1111/imj.15162 · Cited by 3
Yang, Y., Zhang, X., Cui, B., Zhang, H., Wu, Z., Tan, X., Cheng, W., Zhu, X. M., Zhang, F., Qin, H., et al. (2021) · World Journal of Meta-Analysis · doi:10.13105/wjma.v9.i6.496 · Cited by 3
Skladaný, Ľ., Koller, T., Kukla, M., & Šoltýs, K. (2023) · Advances in predictive, preventive and personalised medicine · doi:10.1007/978-3-031-34884-6_9 · Cited by 3
Phages Needed against Resistant Bacteria
Moelling, K. (2020) · Viruses · doi:10.3390/v12070743 · Cited by 3
Advances in Clostridioides difficile therapeutics
Khanna, S. (2021) · Expert Review of Anti-infective Therapy · doi:10.1080/14787210.2021.1874919 · Cited by 3
McGill, S. (2021) · Clinical Infectious Diseases · doi:10.1093/cid/ciab047 · Cited by 3
How to measure academic impact
Morton, B., Ranson, H., & El‐Boghdadly, K. (2022) · Anaesthesia · doi:10.1111/anae.15869 · Cited by 3
The gut microbiome in ARDS: from the “whether” and “what” to the “how”
Bongers, K. S., Stringer, K. A., & Dickson, R. P. (2023) · European Respiratory Journal · doi:10.1183/13993003.02233-2022 · Cited by 3
Bahr, M. M. A., ElRakaiby, M. T., & Mansour, N. M. (2024) · Egyptian Pharmaceutical Journal · doi:10.4103/epj.epj_343_23 · Cited by 2
Next-generation probiotics and animal health
Narzary, Y. (2024) · Elsevier eBooks · doi:10.1016/b978-0-443-22348-8.00021-0 · Cited by 2
Arif, T. B., Damianos, J., Rahman, A., & Hasnain, N. (2025) · Current Gastroenterology Reports · doi:10.1007/s11894-025-01001-6 · Cited by 2
Jin, H., Sun, H., Wang, Q., & Yang, J. (2025) · Archives of Microbiology · doi:10.1007/s00203-025-04410-3 · Cited by 2
Invisible influencers: the tumor microbiome’s impact on immunotherapy in colorectal cancer (CRC)
Omar, T. M., Al-Hussainy, A. F., Jyothi, S. R., Nayak, P. P., Janney, J. B., Singh, G., Polatova, D., Sameer, H. N., Salih, R. M., Adil, M., et al. (2025) · Expert Review of Anticancer Therapy · doi:10.1080/14737140.2025.2579656 · Cited by 2
Diagnosis and Management of Clostridioides difficile
Kelly, C. R., & Feuerstadt, P. (2025) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000003844 · Cited by 2
Syed, S. A., Moayyedi, P., Kao, D. H., Patel, J., Marshall, J. K., Surette, M. G., & Narula, N. (2025) · Inflammatory Bowel Diseases · doi:10.1093/ibd/izaf284 · Cited by 2
Advances in Understanding the Impact of Human Gut Microbiota on Chemotherapy-Induced Neutropenia
He, M., Lin, L., Ouyang, C., Su, L., & Chen, C. (2025) · Biomedicines · doi:10.3390/biomedicines14010055 · Cited by 2
Zhang, Y., Chen, L., Jin, J., Xin, Y., Wang, J., & Zhang, A. (2025) · Experimental Neurology · doi:10.1016/j.expneurol.2025.115631 · Cited by 2
Zhou, C., Li, X., Xing, C., & Cao, C. (2026) · Food Science & Nutrition · doi:10.1002/fsn3.71465 · Cited by 2
Maxan, M.-E., Moens, F., Marzorati, M., Mohamad, M., Yue, C., Said, J., Basit, A. W., Gaisford, S., & Patel, V. (2026) · International Journal of Pharmaceutics · doi:10.1016/j.ijpharm.2026.126678 · Cited by 2
Bahr, M. M. A., ElRakaiby, M. T., Madboli, A. E.-N. A., & Mansour, N. M. (2026) · Biologicals · doi:10.1016/j.biologicals.2026.101881 · Cited by 2
The intestinal microbiota as a key modulator of acute graft-versus-host disease
Paredes, J. E., Schmiester, M., Jenq, R. R., & van den Brink, M. R. M. (2026) · Nature reviews. Cancer · doi:10.1038/s41568-026-00910-6 · Cited by 2
Dai, M., Lin, Y., Gan, R., Shen, X., Park, S. Y., Lee, S., & Su, Q. (2026) · Microbiota Medicine Research · doi:10.1002/mmr3.70004 · Cited by 1
Li, Z., & Zhang, G. Q. (2026) · European journal of medical research · doi:10.1186/s40001-026-04401-0 · Cited by 2
Caserta, S., Martino, E. A., Skafi, M., Vigna, E., Bruzzese, A., Amodio, N., Fiorillo, M., Lucia, E., D’Arrigo, G., Olivito, V., et al. (2026) · Nutrients · doi:10.3390/nu18091400 · Cited by 2
Rao, X., Zou, L., Cai, X., Yao, Y., & Zhong, L. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1761834 · Cited by 2
Molecular studies on the impact of microbiome on anticancer drug resistance
Zhou, K., Lu, P., Xu, H., Wang, L., & Liang, X. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1848345 · Cited by 2
The gut microbiome in colorectal cancer: molecular paradigms and translational frontiers
Liu, Y., & Mei, D. (2026) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2026.1864299 · Cited by 2
The Gut Microbiome in Heart Failure: Pathways to Inflammation and Therapeutic Targets
Vankayala, U. S. A., Sohail, A., George, B., Singh, M., Omar, K., Kreidieh, M., Hasham, A., & Quiel, L. (2026) · Metabolites · doi:10.3390/metabo16060431 · Cited by 3
Prosty, C. J., Carignan, A., Chan, A. K., Chen, Y., Daley, P., Daneman, N., Kandel, C., Longtin, Y., Pérez-Patrigeón, S., Wuerz, T., et al. (2026) · Trials · doi:10.1186/s13063-026-09883-1 · Cited by 2
Self-citationStool donor recruitment – A one-year experience
Aira, A., Rubio-García, E., Fehér, C., González-Suárez, B., Casals‐Pascual, C., & Soriano, À. (2021) · Enfermedades Infecciosas y Microbiología Clínica · doi:10.1016/j.eimc.2021.01.018 · Cited by 2
Tsigalou, C., Konstantinidis, T., Aloizou, A., Bezirtzoglou, E., & Tsakris, A. (2022) · Springer eBooks · doi:10.1007/978-981-19-4800-8_25 · Cited by 2
El‐Salhy, M., & Hatlebakk, J. G. (2024) · Digestive Diseases and Sciences · doi:10.1007/s10620-024-08369-x · Cited by 2
Haroun, E., Lim, S. H., & Dutta, D. (2024) · Interdisciplinary cancer research · doi:10.1007/16833_2024_253 · Cited by 2
Lee, J. W., & Kim, N. (2024) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2024.107 · Cited by 2
Gut microbiota - A key player in breast cancer initiation and progression: A narrative review
Mohamed, N., Madyan, E. F., Yasser, A., Attia, M. G., Abdel-Ghany, S. E., & Sabit, H. (2024) · Cancer Research Statistics and Treatment · doi:10.4103/crst.crst_325_23 · Cited by 2
Tucker, E. C., Angelica, B., Mathias, R. M., Edwards, L., Bryant, R. V., & Costello, S. P. (2025) · Open Forum Infectious Diseases · doi:10.1093/ofid/ofaf149 · Cited by 2
Kusakabe, S., Kurashige, R., Fukushima, K., Shimizu, K., Yoshihara, T., Motooka, D., Nakamura, S., Kurashige, M., Nakata, K., Hino, A., et al. (2025) · International Journal of Hematology · doi:10.1007/s12185-025-04049-2 · Cited by 2
Scarpellini, E., Scarcella, M., Romanelli, G., Basilico, M., Lattanzi, E., Rasetti, C., Abenavoli, L., & Santori, P. (2021) · Gastroenterology Insights · doi:10.3390/gastroent12020022 · Cited by 2
Jo, H. G., & Seo, G. S. (2021) · Korean Journal of Gastroenterology · doi:10.4166/kjg.2021.089 · Cited by 2
“All that is gold does not glitter”: Faecal microbiota transplantation
Kubátová, J. (2022) · Medical Writing · doi:10.56012/dawh4648 · Cited by 2
What Is the Microbiome? A Description of a Social Network
van Praagh, J. B., & Havenga, K. (2023) · Clinics in Colon and Rectal Surgery · doi:10.1055/s-0043-1760863 · Cited by 2
Patents, bioproducts, commercialization, social, ethical, and economic policies on microbiome
Michael, O. S., Adetunji, J. B., Akinwale, E. O., Oluranti, O. I., Ajayi, O. O., Adetunji, C. O., Soladoye, A. O., & Oyewole, O. A. (2024) · Elsevier eBooks · doi:10.1016/b978-0-323-91190-0.00008-4 · Cited by 2
Zhang, X., Li, Y., Li, B., Wu, J., Zhang, J., & Ding, X. (2024) · Heliyon · doi:10.1016/j.heliyon.2024.e32450 · Cited by 2
An optimal normalization method for high sparse compositional microbiome data
Sohn, M. B., Monaco, C. L., & Gill, S. R. (2024) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1012338 · Cited by 2
Faecal microbiota transplantation associated adverse events
Patryn, R. K., Kaźmierczak-Wojtaś, N., Bułaś, L., Boretska, O., Szkultecka-Dębek, M., Drozd, M., & Blicharski, T. (2024) · Current Issues in Pharmacy and Medical Sciences · doi:10.2478/cipms-2024-0028 · Cited by 2
Dolai, S., Ng, J., Hazan, S., Dawson, V., & Borody, T. J. (2021) · Journal of Experimental Pathology · doi:10.33696/pathology.2.020 · Cited by 2
Chakaroun, R., Massier, L., Musat, N., & Kovacs, P. L. (2022) · Experimental and Clinical Endocrinology & Diabetes · doi:10.1055/a-1756-4509 · Cited by 2
SCFAs in T1D: A microbiota-targeted approach for immune tolerance
Mariño, E. (2022) · Current Opinion in Endocrine and Metabolic Research · doi:10.1016/j.coemr.2022.100355 · Cited by 2
Budi, N., Godfrey, J. J., Safdar, N., Shukla, S. K., & Rose, W. E. (2022) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiac324 · Cited by 2
Double-edged sword: impact of fecal microbiome transplants on the gut resistome
Hallowell, H. A., Gao, A. L., & Suez, J. (2022) · Current Opinion in Gastroenterology · doi:10.1097/mog.0000000000000894 · Cited by 2
Interactions Between Microbial Therapeutics and the Endogenous Microbiome
Hallowell, H. A., Gao, A. L., Kelly, K. E., & Suez, J. (2023) · Springer eBooks · doi:10.1007/978-981-99-1463-0_21 · Cited by 2
Fecal Transplantation in Hematopoietic Transplantation
Peled, J. U., & van den Brink, M. R. M. (2023) · Journal of Clinical Oncology · doi:10.1200/jco.23.01169 · Cited by 2
Microbial Therapeutics in Liver Disease
Bajaj, J. S., & Khoruts, A. (2021) · Elsevier eBooks · doi:10.1016/b978-0-12-820472-6.00193-6 · Cited by 2
Jones, J., Pradhan, A., Pizzuti, M., Bland, C. M., & Bookstaver, P. B. (2022) · Antibiotics · doi:10.3390/antibiotics11091247 · Cited by 2
Guideline Recommendations: Optimal Timing of Publication and Resulting Rate of Adoption
Gerding, D. N., & Johnson, S. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa485 · Cited by 2
Cook, L. E., Rees, W. D., Wong, M. Q., Wang, X., Peters, H., Oliveira, L., Lau, T., Mah, R., Bressler, B. L., Gómez, R., et al. (2020) · medRxiv · doi:10.1101/2020.06.05.20114876 · Cited by 2
Fecal Microbiota Transplant: Keep Calm and Carry On, Learning From Experience
Mangioni, D., Alagna, L., Gori, A., & Bandera, A. (2020) · Clinical Infectious Diseases · doi:10.1093/cid/ciaa846 · Cited by 2
Skladaný, Ľ., Kubánek, N., Selčanová, S. A., Žilinčanová, D., Šoltýs, K., Messingerová, L., Lichvár, M., Lafférs, L., Havaj, D. J., Sulejova, K. K., et al. (2024) · Research Square · doi:10.21203/rs.3.rs-3918795/v1 · Cited by 2
Mullish, B. H., Bak, A., Merrick, B., Quraishi, M. N., Goldenberg, S. D., & Williams, H. R. T. (2024) · Journal of Hospital Infection · doi:10.1016/j.jhin.2024.02.021 · Cited by 2
Ishnaiwer, M. M. (2022) · theses.fr (ABES) · doi:10.70675/61486caezc3ecz4191z953bz60a90b36660b · Cited by 2
Donor Screening for Fecal Microbiota Transplantation
Lee, H. H., & Cho, Y. (2020) · Korean Journal of Medicine · doi:10.3904/kjm.2020.95.3.181 · Cited by 1
Fecal Transplant Clinical Trials for Clostridioides Difficile : An Interview with Sahil Khanna
Khanna, S. (2020) · Future Microbiology · doi:10.2217/fmb-2020-0102 · Cited by 1
High-choline diets ameliorate acute graft-versus-host disease
Hu, B., Wu, D., & Xu, Y. (2020) · Blood Science · doi:10.1097/bs9.0000000000000061 · Cited by 1
Seregin, G. Z., Bespyatykh, J., Gospodarik, A. V., Kirillov, M. Y., Ogneva, L. V., Zhilina, S. V., Бурцев, Е. А., Burya, А. E., Vlasova, I., Zhuravel, M. R., et al. (2024) · Pediatric Hematology/Oncology and Immunopathology · doi:10.24287/1726-1708-2024-23-2-98-106 · Cited by 1
Faecal transplantation: the good, the bad and the ugly
Sin, H. C. L., & Haifer, C. (2024) · Internal Medicine Journal · doi:10.1111/imj.16559 · Cited by 1
Arjmand, B., Badamchizadeh, S., Mehran, P., Sarvari, M., Alavi-Moghadam, S., Arjmand, R., Rezaei–Tavirani, M., Janbabaei, G., Vaezi, M., & Larijani, B. A. (2025) · Stem Cell Reviews and Reports · doi:10.1007/s12015-025-10958-w · Cited by 1
Xu, N., He, Y., Yang, G., & Huang, X. (2025) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-025-10799-6 · Cited by 1
Wang, J., Wei, Y., Chen, D., Li, X., Zhang, H., Feng, S., Lu, S., Yang, J., Zeng, Q., He, X., et al. (2025) · Microbial Biotechnology · doi:10.1111/1751-7915.70283 · Cited by 1
Fecal Microbiota Transplantation in Healthy Aging: Challenges and Prospects in Personalized Medicine
Borrego-Ruiz, A., & Borrego, J. J. (2025) · Journal of Molecular and Clinical Medicine · doi:10.31083/jmcm40022 · Cited by 2
Weirauch, T., Yahav, D., Zahavi, I., Würstle, S. M., & Vehreschild, M. J. G. T. (2026) · Infection · doi:10.1007/s15010-025-02718-2 · Cited by 1
Baillieu, V., Delannoy, J., Kapel, N., Barbut, F., Mosca, A., Joly, A. C., Waligora‐Dupriet, A., & Sintes, R. (2026) · World Journal of Microbiology and Biotechnology · doi:10.1007/s11274-025-04767-z · Cited by 1
Minty, M., Lê, S., Addi, M., Canceill, T., Thomas, C., Loubières, P., Burcelin, R., & Blasco‐Baqué, V. (2026) · Reviews in Endocrine and Metabolic Disorders · doi:10.1007/s11154-026-10017-w · Cited by 1
Espiritu, H. M., & Parayao, A. M. (2026) · DNA · doi:10.3390/dna6020018 · Cited by 1
Liu, S., Costa, F. S., & Valenzano, D. R. (2026) · PLoS Biology · doi:10.1371/journal.pbio.3003815 · Cited by 1
Gut microbiota and radiotherapy: towards enhancing radiotherapy efficacy and mitigating toxicities
Li, R., & Huang, J. (2026) · Journal of Holistic Integrative Pharmacy · doi:10.1016/j.jhip.2026.05.007 · Cited by 1
Transplantation of encapsulated fecal microbiota: research progress and future trends
Lin, M.-L., & Gao, H. (2026) · World Journal of Pediatrics · doi:10.1007/s12519-026-01056-z · Cited by 1
Adiga, U., Vasishta, S., Adiga, S., & Augustine, A. A. (2026) · Probiotics and Antimicrobial Proteins · doi:10.1007/s12602-026-11124-5 · Cited by 1
Alanazi, Y. N. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1883259 · Cited by 1
Lu, E., Zhang, M., Zhao, Y., Meng, H., & Xu, Z. Y. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1888117 · Cited by 1
Gong, E. J., Bang, C. S., Lee, J. J., & Baik, G. H. (2026) · The American Journal of Gastroenterology · doi:10.14309/ajg.0000000000004133 · Cited by 1
Zammar, K., AbuAlrob, M. A., Ali, M. A., Lattanzi, S., & Mesraoua, B. (2026) · Epilepsia Open · doi:10.1002/epi4.70325 · Cited by 1
Yoon, S. J., Eom, J. A., & Suk, K. T. (2026) · Frontiers in Immunology · doi:10.3389/fimmu.2026.1864805 · Cited by 1
Palabıyık, E. (2026) · Therapeutic Innovation & Regulatory Science · doi:10.1007/s43441-026-01033-8 · Cited by 1
Metadata
- Authors
- DeFilipp, Z., Bloom, P. P., Torres Soto, M., Mansour, M. K., Sater, M. R. A., Huntley, M. H., Turbett, S., Chung, R. T., Chen, Y.-B., & Hohmann, E. L.
- Affiliations
- Harvard University (US)
- From the Blood and Marrow Transplant Program (Z.D., Y.-B.C.), the Liver Center, Division of Gastroenterology (P.P.B., R.T.C.), and the Division of Infectious Diseases (M.T.S., M.K.M., S.T., E.L.H.), Massachusetts General Hospital, Harvard Medical School (Z.D., P.P.B., M.T.S., M.K.M., S.T., R.T.C., Y.-B.C., E.L.H.), and Day Zero Diagnostics (M.R.A.S., M.H.H.) — all in Boston.
- ORCID
- Venue
- New England Journal of Medicine
- Publisher
- Massachusetts Medical Society
- Published
- 2019-11-21
- Volume
- 381
- Issue
- 21
- Pages
- 2043-2050
- ISSN
- 0028-4793 (ISSN-L)
- 1533-4406
- OpenAlex
- W2982566732
- Cited by
- 1,281
- References
- 26
- Citations by year
- 2026: 202 · 2025: 160 · 2024: 158 · 2023: 175 · 2022: 169 · 2021: 184 · 2020: 222 · 2019: 10
- FWCI
- 112.06
- Type
- journal article
- Language
- en
- Open access
- bronze
- doi.org
- Locations
- New England Journal of Medicine (publishedVersion)
- PubMed (publishedVersion)
- Funders
- Massachusetts General Hospital
- Topics
- Health Sciences › Medicine › Infectious Diseases › Clostridium difficile and Clostridium perfringens research
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Gut microbiota and health
- Health Sciences › Medicine › Microbiology (medical) › Antibiotic Resistance in Bacteria
- Keywords
- drug-resistant Escherichia coli, bacteremia, fecal microbiota transplantation, donor screening, genome sequencing
- MeSH terms
- Fecal Microbiota Transplantation, Aged, beta-Lactamases, Escherichia coli, Feces, Hepatic Encephalopathy, Humans, Male, Myelodysplastic Syndromes, Bacteremia, Fatal Outcome, Drug Resistance, Bacterial, Dysbiosis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
